REGELTEC.COM: Keyword Density Checker

Total words: 1375 | 2-word phrases: 356 | 3-word phrases: 392 | 4-word phrases: 410

PAGE INFO

Title	Try to keep the title under 60 characters (63 characters) ReGelTec, Inc. \| HYDRAFIL \| Injectable Gel \| Degenerative Discs
Description	Try to keep the meta description between 50 - 160 characters (91 characters) ReGelTec is developing HYDRAFIL, a next generation treatment for degenerative disc disease.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	degenerative disc disease	10	2.55%
2	low back pain	5	1.28%
3	chronic low back	4	1.02%
4	pain caused by	3	0.77%
5	back pain due	3	0.77%
6	pain due to	3	0.77%
7	of pain and	3	0.77%
8	abstract award at	2	0.51%
9	award at the	2	0.51%
10	at the 6th	2	0.51%
11	the 6th annual	2	0.51%
12	6th annual american	2	0.51%
13	annual american society	2	0.51%
14	american society of	2	0.51%
15	society of pain	2	0.51%
16	neuroscience annual meeting	2	0.51%
17	fda approves ide	2	0.51%
18	the fda approves	2	0.51%
19	approves ide for	2	0.51%
20	top abstract award	2	0.51%
21	regeltec inc announced	2	0.51%
22	inc announced that	2	0.51%
23	pivotal study of	2	0.51%
24	study of hydrafil®	2	0.51%
25	of hydrafil® for	2	0.51%
26	hydrafil® for chronic	2	0.51%
27	lower back pain	2	0.51%
28	for chronic low	2	0.51%
29	ide for regeltec’s	2	0.51%
30	by degenerative disc	2	0.51%

#	Keyword	Frequency	Density
1	chronic low back pain	4	0.98%
2	back pain due to	3	0.73%
3	society of pain and	2	0.49%
4	abstract award at the	2	0.49%
5	award at the 6th	2	0.49%
6	at the 6th annual	2	0.49%
7	the 6th annual american	2	0.49%
8	6th annual american society	2	0.49%
9	annual american society of	2	0.49%
10	american society of pain	2	0.49%
11	low back pain caused	2	0.49%
12	low back pain due	2	0.49%
13	fda approves ide for	2	0.49%
14	approves ide for regeltec’s	2	0.49%
15	pivotal study of hydrafil®	2	0.49%
16	study of hydrafil® for	2	0.49%
17	to treat low back	2	0.49%
18	of hydrafil® for chronic	2	0.49%
19	regeltec inc announced that	2	0.49%
20	hydrafil® for chronic low	2	0.49%
21	the fda approves ide	2	0.49%
22	for chronic low back	2	0.49%
23	back pain caused by	2	0.49%
24	pain caused by degenerative	2	0.49%
25	caused by degenerative disc	2	0.49%
26	by degenerative disc disease	2	0.49%
27	studied to treat low	2	0.49%
28	regeltec’s hydrafil injectable hydrogel	2	0.49%
29	for his presentation of	1	0.24%
30	back pain patients treated	1	0.24%
31	hydrogel studied to treat	1	0.24%
32	injectable hydrogel studied to	1	0.24%
33	hydrafil injectable hydrogel studied	1	0.24%
34	system regeltec’s hydrafil injectable	1	0.24%
35	hydrafil system regeltec’s hydrafil	1	0.24%
36	regeltec’s hydrafil system regeltec’s	1	0.24%
37	pain patients treated with	1	0.24%
38	low back pain patients	1	0.24%
39	aspn for his presentation	1	0.24%
40	on chronic low back	1	0.24%

#	URL	Whois	Check
1	https://regeltec.lhrdigital.com/degenerative-disc-disease/	Whois	lhrdigital.com
2	https://regeltec.lhrdigital.com/hydrafil/	Whois	lhrdigital.com
3	https://regeltec.lhrdigital.com/	Whois	lhrdigital.com